Information

You are on the new improved site. You can view the old site in view-only mode here until June 27, 2026

loading
Recombinant Adeno-Associated Virus for the Generation of Autologous,Gene-Modified Tumor Vaccines: Evidence for a High Transduction Efficiency into Primary Epithelial Cancer Cells